简介：
Overview
This article describes a two-stage method to induce chronic kidney disease (CKD) in the Lewis rat. The approach combines surgical removal of renal mass, nitric oxide inhibition, and a high-salt diet to create a model that mimics human CKD.
Key Study Components
Area of Science
- Nephrology
- Animal Models
- Chronic Kidney Disease Research
Background
- Chronic kidney disease is a significant health issue.
- Animal models are essential for studying CKD mechanisms.
- The Lewis rat is a suitable model for such studies.
- Inducing CKD can help in testing new therapeutic interventions.
Purpose of Study
- To establish a reliable model of CKD in the Lewis rat.
- To investigate the causal mechanisms of CKD.
- To facilitate the development of novel therapeutic strategies.
Methods Used
- Administration of nitric oxide blocker (LNNA) for four weeks.
- Surgical removal of the entire right kidney.
- Subsequent removal of two-thirds of the left kidney one week later.
- Monitoring renal failure through urine and blood analysis.
Main Results
- Successful induction of CKD in the Lewis rat model.
- Measurement of protein levels and hematocrit in urine.
- Assessment of blood plasma and urine for UIA.
- Tracking of systolic blood pressure changes over time.
Conclusions
- The model effectively simulates human CKD.
- It provides insights into the mechanisms of renal failure.
- Potential for testing new therapeutic interventions for CKD.
What is the significance of using the Lewis rat model?
The Lewis rat model is significant for studying chronic kidney disease as it closely resembles human CKD, allowing for better understanding and testing of therapies.
How does the surgical procedure contribute to CKD induction?
The surgical removal of renal mass leads to a reduction in kidney function, which is a key factor in the development of chronic kidney disease.
What role does nitric oxide inhibition play in this study?
Nitric oxide inhibition is used to exacerbate kidney damage, thereby enhancing the model's resemblance to human CKD conditions.
What measurements are taken to assess CKD progression?
Measurements include protein levels in urine, hematocrit, UIA in blood and urine, and systolic blood pressure.
Can this model be used for testing new drugs?
Yes, this model is suitable for testing new therapeutic interventions aimed at treating chronic kidney disease.
How long does the entire procedure take?
The procedure spans several weeks, including the administration of LNNA and the surgical interventions.
繁體中文
